Human CD40 Ligand/TNFSF5 DuoSet ELISA, 15 Plate



Product Details

Reactivity HuSpecies Glossary
Applications ELISA

Order Details

Human CD40 Ligand/TNFSF5 DuoSet ELISA, 15 Plate Summary

Assay Type
Solid Phase Sandwich ELISA
See PDF Datasheet for details
See PDF Datasheet for details
Spike Recovery
See PDF Datasheet for details
Sample Volume
See PDF Datasheet for details


Application Notes
No significant interference observed with available related molecules.
Read Publications using DY617.

Packaging, Storage & Formulations

Store the unopened product at 2 - 8 °C. Do not use past expiration date.


This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Human CD40 Ligand/TNFSF5 DuoSet ELISA, 15 Plate

  • CD154 antigen
  • CD154
  • CD40 antigen ligand
  • CD40 Ligand
  • CD40L
  • CD40-L
  • CD40LG
  • CD40LIGM
  • gp39
  • hCD40L
  • HIGM1
  • T-B cell-activating molecule
  • T-BAM
  • T-cell antigen Gp39
  • TNF-related activation protein
  • TNFSF5
  • TRAP
  • TRAPtumor necrosis factor (ligand) superfamily, member 5 (hyper-IgM syndrome)
  • tumor necrosis factor (ligand) superfamily member 5
  • Tumor necrosis factor ligand superfamily member 5


CD40 Ligand, also known as TNFSF5, CD154, TRAP, and gp39, is a trimeric protein that is expressed in transmembrane and soluble forms. It is expressed by many immune cell types as well as by endothelial and smooth muscle cells of the vasculature. It binds to CD40 on antigen presenting cells, platelets, and endothelial and epithelial cells, leading to enhanced B cell activation and T cell dependent humoral immune responses. CD40 Ligand dysregulation contributes to immune pathology in AIDS, atherosclerosis, atherothrombosis, and restenosis.

Customers Who Viewed This Item Also Viewed...

Species: Hu
Applications: Flow, Func, ICC/IF, IHC, IHC-Fr, IHC-P
Species: Hu
Applications: BA
Species: Hu
Applications: BA
Species: Hu
Applications: CyTOF-ready, ELISA, Flow, ICC/IF, IHC, IHC-P, PA, WB
Species: Hu, Mu
Applications: Flow-IC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, WB
Species: Hu
Applications: CyTOF-ready, Dual ISH-IHC, ELISA(Cap), ELISA(Det), ELISA(Sta), Flow, IHC, Neut
Species: Hu
Applications: BA
Species: Ca, Hu, Mu, Po, Rb, Rt
Applications: Dual ISH-IHC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, Simple Western, WB
Species: Mu
Applications: ELISA
Species: Hu
Applications: ELISA
Species: Hu, Mu, Rt
Applications: Flow, ICC/IF, IHC, IHC-Fr, IHC-P, KO, WB
Species: Mu
Applications: BA
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, PEP-ELISA, WB
Species: Hu
Applications: AgAct, ICC, WB
Species: Hu
Applications: BA
Species: Mu, Rt
Applications: Cell Depl, CyTOF-ready, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, InhibTFunc
Species: Av, Hu, Mu, Rt
Applications: CyTOF-ready, Flow-CS, Flow, IHC, IHC-P, WB
Species: Hu
Applications: ELISA

Publications for CD40 Ligand/TNFSF5 (DY617)(9)

We have publications tested in 1 confirmed species: Human.

Filter By Application
All Applications
Filter By Species
All Species
Showing Publications 1 - 9 of 9.
Publications using DY617 Applications Species
M Lenz, R Schönbauer, S Stojkovic, J Lee, C Gatterer, M Lichtenaue, V Paar, M Emich, M Fritzer-Sz, J Strametz-J, S Graf, M Sponder RANTES and CD40L under Conditions of Long-Term Physical Exercise: A Potential Link to Adaptive Immunity Oncogene, 2022-07-16;19(14):. 2022-07-16 [PMID: 35886510] (Human) Human
L Song, X Zhao, R Chen, J Li, J Zhou, C Liu, P Zhou, Y Wang, Y Chen, H Zhao, H Yan Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetes Cardiovascular Diabetology, 2022-05-20;21(1):80. 2022-05-20 [PMID: 35596184] (Human) Human
RV da Costa S, LC Torres, EJA da Fonte, MJG Mello, JT de Oliveir, MC da Matta Analysis of physical activity and plasma levels of soluble CD40 and CD40L in older people with gastrointestinal tract cancer Experimental gerontology, 2022-01-11;0(0):111677. 2022-01-11 [PMID: 35031307] (Human) Human
A Topf, M Mirna, N Bacher, V Paar, C Edlinger, LJ Motloch, S Gharibeh, M Bannehr, UC Hoppe, M Lichtenaue The Value of Fetuin-A as a Predictor to Identify Takotsubo Patients at Risk of Cardiovascular Events Journal of cardiovascular development and disease, 2021-10-05;8(10):. 2021-10-05 [PMID: 34677196] (Human) Human
S Piantoni, F Regola, S Masneri, M Merletti, T Lowin, P Airò, A Tincani, F Franceschi, L Andreoli, G Pongratz Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy Frontiers in Pharmacology, 2021-05-21;12(0):666971. 2021-05-21 [PMID: 34093196] (Human) Human
Serological signatures of clinical cure following successful treatment with sodium stibogluconate in Ethiopian visceral leishmaniasis Cytokine, 2016-12-08;91(0):6-9. 2016-12-08 [PMID: 27940090] (Human) Human
Joseph W Jackson Novel Antiplatelet Activity of Minocycline Involves Inhibition of MLK3-p38 Mitogen Activated Protein Kinase Axis PLoS ONE, 2016-06-06;11(6):e0157115. 2016-06-06 [PMID: 27270236] (Human) Human
Davidson D, Schifitto G, Maggirwar S Valproic acid inhibits the release of soluble CD40L induced by non-nucleoside reverse transcriptase inhibitors in human immunodeficiency virus infected individuals. PLoS ONE, 2013-03-28;8(3):e59950. 2013-03-28 [PMID: 23555843] (Human) Human
Koutroubakis IE, Theodoropoulou A, Xidakis C, Sfiridaki A, Notas G, Kolios G, Kouroumalis EA Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease. Eur J Gastroenterol Hepatol, 2004-11-01;16(11):1147-52. 2004-11-01 [PMID: 15489574] (Human) Human

Reviews for CD40 Ligand/TNFSF5 (DY617) (0)

There are no reviews for CD40 Ligand/TNFSF5 (DY617). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for CD40 Ligand/TNFSF5 (DY617). (Showing 1 - 1 of 1 FAQs).

  1. I am looking for paired ABs for use in detecting CD40L (rat) by ELISA. Do you have such a reagent(s) available?
    • Unfortunately we currently do not have any CD40 Ligand antibody pairs that have been validated in Rat. The only antibody pairs we offer for CD40L are validated in Human. I apologize for this inconvenience. If you would be interested in testing one of our products in Rat I'd like to invite you to participate in our Innovators Reward Program. Please contact us at with any questions regarding this program.

Additional CD40 Ligand/TNFSF5 Products

Bioinformatics Tool for CD40 Ligand/TNFSF5 (DY617)

Discover related pathways, diseases and genes to CD40 Ligand/TNFSF5 (DY617). Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
Visit Tool

Diseases for CD40 Ligand/TNFSF5 (DY617)

Discover more about diseases related to CD40 Ligand/TNFSF5 (DY617).

Pathways for CD40 Ligand/TNFSF5 (DY617)

View related products by pathway.

PTMs for CD40 Ligand/TNFSF5 (DY617)

Learn more about PTMs related to CD40 Ligand/TNFSF5 (DY617).

Blogs on CD40 Ligand/TNFSF5

There are no specific blogs for CD40 Ligand/TNFSF5, but you can read our latest blog posts.

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Review this Product

Be the first to review our Human CD40 Ligand/TNFSF5 DuoSet ELISA, 15 Plate and receive a gift card or discount.


Gene Symbol CD40LG